Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Mark Weems

Neonatal-Perinatal Medicine Memphis, TN Medical Doctor

NPI 1477793362 CMS profile 519616

853 Jefferson Ave, Rout Bldg E201, Memphis, TN 38103

Open in the dashboard

General payments

$142,110

294 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Mark Weems of Memphis, TN is reported in the CMS Open Payments database as having received $142,110 across 294 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Neonatal-Perinatal Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,111 4
2024 General $9,766 22
2023 General $11,598 30
2022 General $55,826 99
2021 General $29,821 80
2020 General $4,484 8
2019 General $29,504 51

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Mark Weems
  • Neonatal-Perinatal Medicine median
  • Middle half of Neonatal-Perinatal Medicine
  • National median

In program year 2025, general payments to Mark Weems were reported at $1,111. Among 879 Neonatal-Perinatal Medicine profiles paid that year, the median was $77 and the middle half received between $26 and $145.

Show as a table
Year Mark Weems Neonatal-Perinatal Medicine median Middle half National median
2019 $29,504 $70 $22–$125 $163
2020 $4,484 $39 $18–$108 $114
2021 $29,821 $49 $18–$122 $132
2022 $55,826 $47 $21–$149 $149
2023 $11,598 $49 $23–$140 $160
2024 $9,766 $65 $24–$132 $164
2025 $1,111 $77 $26–$145 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $141,973 293 payments
  2. Penumbra, Inc. $138 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for serving as faculty or as a speaker for a medical education program $67,100 36 payments
  2. Travel and Lodging $22,854 135 payments
  3. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $19,250 11 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $15,194 11 payments
  5. Consulting Fee $11,138 11 payments
  6. Food and Beverage $6,575 90 payments
Products named General payments · program years 2019–2025
  1. AMPLATZER Structural Heart $36,457 66 payments
  2. AMPLATZER Occluders Cardiac Arrhythmias and Heart Failure $31,583 55 payments
  3. AMPLATZER Occluders Structural Heart $29,679 78 payments
  4. MITRACLIP $14,996 19 payments
  5. AMPLATZER TALISMAN $12,494 18 payments
  6. AMPLATZER PICCOLO $11,915 41 payments
  7. AMPLATZER AMULET $1,100 2 payments
  8. JETI ALL IN ONE NON-STERILE KIT $550 1 payment
  9. AMPLATZER Structural Heart $515 7 payments
  10. Piccolo Xpress $417 3 payments
  11. Other $197 2 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

294 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neonatal-Perinatal Medicine in Tennessee

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record